Citius Oncology Inc (CTOR)

$1.25 -0.08 (-6.02%)
Market Cap 111.07M
Revenue (ttm) 0.00
Net Income (ttm) -21.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.35
Volume 95,900
Avg Vol 228,378
Day's Range N/A - N/A
Shares Out 83.51M
Stochastic %K 0%
Beta 2.89
Analysts Strong Sell
Price Target $6.00

Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: (908) 967-6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
TwongStocks
TwongStocks Nov. 15 at 1:19 AM
$CTOR Armistice Capital filed a 13G https://www.sec.gov/Archives/edgar/data/1601086/000117266125005175/xslSCHEDULE_13G_X01/primary_doc.xml Reporting ownership of 7,675,911 shares, 9.79%
0 · Reply
donein12
donein12 Nov. 14 at 7:20 PM
$CTOR Mazur has to be one of the most inefficient CEO's for any non SCAM emerging biotech company ever. He is so bad, he makes the US Congress and Senate look as an efficent branch of Gov't.
0 · Reply
Jojackthewonderskunk
Jojackthewonderskunk Nov. 13 at 2:41 PM
$CTOR dumb question, but do they HAVE to announce they've launched the product? Is it possible its out there being sold without them having to issue an 8k?
3 · Reply
donein12
donein12 Nov. 12 at 3:15 PM
$CTOR All interest in CTOR currently has all but disappeared. 3.7k shares traded in the first 45 mins of trading.
0 · Reply
SweStonk
SweStonk Nov. 11 at 8:20 PM
$CTOR I have heard that many times and still my entire portfolio are up 400% the past 5 years 😂 You should have sold when I posted that I did @ $2.66. Went from my 1.8 entry to 2.7 and down below and now @ 1.34. People gonna sell to write of tax after buying in all the way up to $6. Launch will happen in late feb when same people who write of taxes are able to buy back in.
1 · Reply
Kingcrab3333
Kingcrab3333 Nov. 11 at 8:10 PM
$CTOR
0 · Reply
NYC100
NYC100 Nov. 11 at 7:52 PM
$CTOR you’ll see
0 · Reply
SweStonk
SweStonk Nov. 11 at 7:34 PM
$CTOR CTXR had another(ML)which doesnt matter for CTOR at all so I dont understand why you put that as bullish? Have you even done any kind of DD here? You wont get far by not doing it. Probably why you are invested in this dud. ML is dead they even said it themselves when they went from we will take it to market to we will sell it. This is their second drug who where supposed to change the industry and bring in billions that went into the ground. They did the exact same thing to Halo. Which is now forgotten and no existent. When Mazur is done with CTOR it will be the same. He will use your money to buy something retarded as lymphir spin it off and put lymphir into the ground while he keep shorting with his cayman account and his buddies. Mazur have most likely broken the law with his timeline statements. It isnt allowed to set or say a timeline only to save the SP. He probably knew all along the real timeline but put up fake ones to hinder the SP to drop below $1.
0 · Reply
NYC100
NYC100 Nov. 11 at 5:28 PM
$CTOR they have another drug to submit to FDA, and for some reason they don’t do it🤷‍♂️
0 · Reply
SweStonk
SweStonk Nov. 11 at 4:03 PM
$CTOR This has become a prove it first kinda stock. This wont move until they announce launch and there are many doubts if they ever will. Even with launch I doubt it will run much. I doubt many believe these crazy high valuations. + I have never seen a launch this slow and I have seen many before. It is almost like management have done all these delays on purpose. They act like they want CTXR and CTOR to be delayed and crushed ever since the halt for ML never happened. He bought E7 because he new ML was doomed to fail and trying to blow up its value but investors see right through him this time compared to ML. He have had many different run ups from paid pumpers but never done a dilution on the runup? He know these paid pumps push price lower still he continue to pay for them. He have probably been shorting both CTXR and CTOR from his caymans account.
0 · Reply
Latest News on CTOR
Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch

Oct 20, 2025, 8:37 AM EDT - 25 days ago

Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch

Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences

Oct 17, 2025, 5:00 PM EDT - 4 weeks ago

Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences

CTXR

Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™

Oct 16, 2025, 8:47 AM EDT - 4 weeks ago

Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™

CTXR

Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe

Oct 7, 2025, 8:47 AM EDT - 5 weeks ago

Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

Sep 10, 2025, 4:30 PM EDT - 2 months ago

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

CTXR

Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

Sep 9, 2025, 8:30 AM EDT - 2 months ago

Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

CTXR

Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch

Aug 22, 2025, 8:47 AM EDT - 3 months ago

Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch

CTXR

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

Aug 12, 2025, 4:30 PM EDT - 3 months ago

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

Citius Oncology Announces Closing of $9.0 Million Public Offering

Jul 17, 2025, 4:30 PM EDT - 4 months ago

Citius Oncology Announces Closing of $9.0 Million Public Offering

CTXR

Citius Oncology Announces Pricing of $9.0 Million Public Offering

Jul 16, 2025, 9:15 AM EDT - 4 months ago

Citius Oncology Announces Pricing of $9.0 Million Public Offering

CTXR

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

Jul 15, 2025, 8:32 AM EDT - 4 months ago

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

CTXR

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

Jun 17, 2025, 8:08 AM EDT - 5 months ago

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

CTXR

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

May 14, 2025, 4:30 PM EDT - 6 months ago

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 5, 2025, 8:37 AM EDT - 6 months ago

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

CTXR

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 14, 2025, 4:30 PM EST - 9 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

CTXR

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 14, 2025, 4:30 PM EST - 9 months ago

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Feb 6, 2025, 8:55 AM EST - 10 months ago

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

CTXR

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Jan 7, 2025, 8:08 AM EST - 11 months ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

CTXR

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Jan 6, 2025, 7:50 AM EST - 11 months ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

CTXR

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Dec 27, 2024, 5:00 PM EST - 11 months ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

TwongStocks
TwongStocks Nov. 15 at 1:19 AM
$CTOR Armistice Capital filed a 13G https://www.sec.gov/Archives/edgar/data/1601086/000117266125005175/xslSCHEDULE_13G_X01/primary_doc.xml Reporting ownership of 7,675,911 shares, 9.79%
0 · Reply
donein12
donein12 Nov. 14 at 7:20 PM
$CTOR Mazur has to be one of the most inefficient CEO's for any non SCAM emerging biotech company ever. He is so bad, he makes the US Congress and Senate look as an efficent branch of Gov't.
0 · Reply
Jojackthewonderskunk
Jojackthewonderskunk Nov. 13 at 2:41 PM
$CTOR dumb question, but do they HAVE to announce they've launched the product? Is it possible its out there being sold without them having to issue an 8k?
3 · Reply
donein12
donein12 Nov. 12 at 3:15 PM
$CTOR All interest in CTOR currently has all but disappeared. 3.7k shares traded in the first 45 mins of trading.
0 · Reply
SweStonk
SweStonk Nov. 11 at 8:20 PM
$CTOR I have heard that many times and still my entire portfolio are up 400% the past 5 years 😂 You should have sold when I posted that I did @ $2.66. Went from my 1.8 entry to 2.7 and down below and now @ 1.34. People gonna sell to write of tax after buying in all the way up to $6. Launch will happen in late feb when same people who write of taxes are able to buy back in.
1 · Reply
Kingcrab3333
Kingcrab3333 Nov. 11 at 8:10 PM
$CTOR
0 · Reply
NYC100
NYC100 Nov. 11 at 7:52 PM
$CTOR you’ll see
0 · Reply
SweStonk
SweStonk Nov. 11 at 7:34 PM
$CTOR CTXR had another(ML)which doesnt matter for CTOR at all so I dont understand why you put that as bullish? Have you even done any kind of DD here? You wont get far by not doing it. Probably why you are invested in this dud. ML is dead they even said it themselves when they went from we will take it to market to we will sell it. This is their second drug who where supposed to change the industry and bring in billions that went into the ground. They did the exact same thing to Halo. Which is now forgotten and no existent. When Mazur is done with CTOR it will be the same. He will use your money to buy something retarded as lymphir spin it off and put lymphir into the ground while he keep shorting with his cayman account and his buddies. Mazur have most likely broken the law with his timeline statements. It isnt allowed to set or say a timeline only to save the SP. He probably knew all along the real timeline but put up fake ones to hinder the SP to drop below $1.
0 · Reply
NYC100
NYC100 Nov. 11 at 5:28 PM
$CTOR they have another drug to submit to FDA, and for some reason they don’t do it🤷‍♂️
0 · Reply
SweStonk
SweStonk Nov. 11 at 4:03 PM
$CTOR This has become a prove it first kinda stock. This wont move until they announce launch and there are many doubts if they ever will. Even with launch I doubt it will run much. I doubt many believe these crazy high valuations. + I have never seen a launch this slow and I have seen many before. It is almost like management have done all these delays on purpose. They act like they want CTXR and CTOR to be delayed and crushed ever since the halt for ML never happened. He bought E7 because he new ML was doomed to fail and trying to blow up its value but investors see right through him this time compared to ML. He have had many different run ups from paid pumpers but never done a dilution on the runup? He know these paid pumps push price lower still he continue to pay for them. He have probably been shorting both CTXR and CTOR from his caymans account.
0 · Reply
NYC100
NYC100 Nov. 10 at 8:58 PM
$CTOR up now ✈️
0 · Reply
Jvukti01
Jvukti01 Nov. 10 at 8:29 PM
$CTOR why down today
0 · Reply
SweStonk
SweStonk Nov. 10 at 8:02 PM
$CTOR $CTXR Welcome all new bagholders. Remember to take your losses unless you want to become the 90 percentage bagholders that are down 98% Mazur still havent learned his lesson. First he destroyed CTXR and now CTOR. When is management gonna act and kick him of the board? He clearly dont know how to run a company and he have zero trust left.
1 · Reply
donein12
donein12 Nov. 10 at 7:09 PM
$CTOR In the last Q&A (Late Oct.1925) it was stated they plan to initiate sales by the end of Oct.2025. It is now 11/10/25 and nothing. Apparently is it BS, Standard for a Mazur run company and if this continues long enough, CTOR possibly could drop below a $1 again.
1 · Reply
Stockttwits619
Stockttwits619 Nov. 8 at 12:15 AM
$VIVK $CTOR $FBLG $BIAF 👁️👁️👁️👁️👁️ great potential to trend
0 · Reply
whathappenedtomyaccount
whathappenedtomyaccount Nov. 7 at 8:34 PM
$CTOR the scary thing here is that we are now well below the last offering purchase price...did that purchaser dump?
1 · Reply
SweStonk
SweStonk Nov. 7 at 8:10 PM
$CTOR Sure we down because of market. XBI are at its highest point in years and still CTOR is pushing lower lows each day..... This isnt down because of "market".
1 · Reply
NYC100
NYC100 Nov. 7 at 7:06 PM
$CTOR maybe, everyone should remember that the market is completely down not just this stock 
1 · Reply
SweStonk
SweStonk Nov. 7 at 5:13 PM
$CTOR wont see a launch this year..... Tax season and holidays getting to close. If you ever gonna see a launch it will be in late feb.
0 · Reply
MaryAlexander707
MaryAlexander707 Nov. 7 at 4:42 PM
$CTOR holds consistent gains. AITX continues advancing its AI-driven perimeter protection technologies that improve security and cost efficiency.
1 · Reply
whathappenedtomyaccount
whathappenedtomyaccount Nov. 6 at 7:11 PM
$CTOR god will judge you mazur
0 · Reply
SweStonk
SweStonk Nov. 5 at 9:24 PM
$CTOR $CTXR when will bulls realize it all is just a big scam? Do bulls even have any kind of numbers that dont come from Mazur himself? CTXR 1.8b market. Defencath who get to treat every patient to prevent infections dont make anywhere near that. Do you remember when an analyst asked about Defencath as competition and he lied straight out and said defencath will never compete against us. It is not the "same". Well duuh? It prevent infections...... CTOR 400m/y (according to Mazur) Entire market is estimated at 400m/y It is third in line. Competition with better treatment dont(never reached 100m/y)even make 100m/y and have been on market for years ML was second in line it is worthless today how do you think a third in line will be? Why do you think they sold E7 former approved drug with slam dunk approval for 40m when according to Mazur will have a revenue of 400m/y? It was on market before and they sure as hell knew what sales to expect and 40m was to good to say no to.
1 · Reply